Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
- 6 October 2016
- journal article
- practice guideline
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 11 (1), 1-30
- https://doi.org/10.1007/s12072-016-9760-3
Abstract
Hepatic fibrosis is a common pathway leading to liver cirrhosis, which is the end result of any injury to the liver. Accurate assessment of the degree of fibrosis is important clinically, especially when treatments aimed at reversing fibrosis are being evolved. Despite the fact that liver biopsy (LB) has been considered the "gold standard" of assessment of hepatic fibrosis, LB is not favored by patients or physicians owing to its invasiveness, limitations, sampling errors, etc. Therefore, many alternative approaches to assess liver fibrosis are gaining more popularity and have assumed great importance, and many data on such approaches are being generated. The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on liver fibrosis in 2007, with a mandate to develop consensus guidelines on various aspects of liver fibrosis relevant to disease patterns and clinical practice in the Asia-Pacific region. The first consensus guidelines of the APASL recommendations on hepatic fibrosis were published in 2009. Due to advances in the field, we present herein the APASL 2016 updated version on invasive and non-invasive assessment of hepatic fibrosis. The process for the development of these consensus guidelines involved review of all available published literature by a core group of experts who subsequently proposed consensus statements followed by discussion of the contentious issues and unanimous approval of the consensus statements. The Oxford System of the evidence-based approach was adopted for developing the consensus statements using the level of evidence from one (highest) to five (lowest) and grade of recommendation from A (strongest) to D (weakest). The topics covered in the guidelines include invasive methods (LB and hepatic venous pressure gradient measurements), blood tests, conventional radiological methods, elastography techniques and cost-effectiveness of hepatic fibrosis assessment methods, in addition to fibrosis assessment in special and rare situations.Keywords
This publication has 186 references indexed in Scilit:
- An evaluation of the potential cost‐effectiveness of non‐invasive testing strategies in the diagnosis of significant liver fibrosisJournal of Gastroenterology and Hepatology, 2009
- Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)Hepatology International, 2008
- Detection of novel biomarkers of liver cirrhosis by proteomic analysisHepatology, 2008
- Magnetic Resonance Elastography for the Noninvasive Staging of Liver FibrosisGastroenterology, 2008
- Grading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ, 2008
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008
- Comparison of Liver Perfusion Parameters Studied With Conventional Extravascular and Experimental Intravascular CT Contrast AgentsAcademic Radiology, 2007
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996